article thumbnail

Cannabinoids and Cannabinoid Receptors: What Are They?

United Patients Group

Introduction The endocannabinoid system (ECS) is a group of cannabinoid receptors located throughout the body, but particularly in the brain and central nervous system, that interact with cannabis compounds. There are two major cannabinoid receptors: CB1 and CB2. There are two major cannabinoid receptors: CB1 and CB2.

article thumbnail

The Impact of Medical Marijuana on Mental Health

MMJ Recs

It’s a time for both individuals and organizations to engage in conversations, initiatives, and activities aimed at reducing stigma, increasing understanding, and fostering empathy surrounding mental health conditions. They bind to cannabinoid receptors to regulate cellular activity and maintain balance.

Marijuana 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biggest Benefits of Cannabis You May Be Missing Out On: Acidic Cannabinoids (CBDA / CBGA / THCA)

Healer

While the focus has been on neutral cannabinoids, new research –and my own clinical observations– indicate that cannabinoids in their original, acidic form possess incredible healing properties that work both together with and different from their neutral counterparts. What are Acidic Cannabinoids?

article thumbnail

Green-Flower Media—Things You Never Knew About Cannabis Tinctures

Cannabis Law Report

by Rachel Garland, Green-Flower Media. Pharmacopeia as a treatment for several conditions including: tetanus, gout, tonsillitis, alcoholism, menstrual cramps, cholera, arthritis, and many others. 4) Tinctures give you different cannabinoid options. Are you targeting a specific condition or ailment?

article thumbnail

ZYUS Life Sciences Launches Two Softgel Cannabinoid Products for Direct to Patient Sales in Canada

Cannabis Law Report

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

article thumbnail

ZYUS Life Sciences Launches New Medical Cannabinoid Formulation for Direct to Patient Sales in Canada

Cannabis Law Report

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

article thumbnail

Ukraine Medical Cannabis Legalization Pending Amid Ongoing War

Veriheal

Halilovic told the media that, “Once The fighting ends, the new fight will start. Medical cannabis can help with a multitude of different conditions like; chronic pain, inflammation , stress, anxiety , depression , nausea , loss of appetite, headaches , insomnia , and more. To rebuild cities. And to heal.